R&G Pharma (301333.SZ) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Oct28

R&G Pharma released FY2025 9 Months Earnings on October 28 During-Market (BJT), Actual Revenue CNY 607.37 M, Actual EPS CNY 1.001

01:00

R&G Pharma released FY2025 Q3 earnings on October 28 During-Market (BJT), actual revenue CNY 227.71 M, actual EPS CNY 0.3599

01:00

Oct21

R&G Pharma FY2025 Q3 Earnings Release on October 29 During-Market (BJT)

00:59

Aug27

R&G Pharma released FY2025 Semi-Annual earnings on August 27 Pre-Market (BJT), actual revenue CNY 379.66 M, actual EPS CNY 0.64

01:00

R&G Pharma released FY2025 Q2 earnings on August 27 Pre-Market (BJT), actual revenue CNY 206.82 M, actual EPS CNY 0.3711

01:00

Aug20

R&G Pharma to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

01:19

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 227.71 M, Net Income 34.45 M, EPS 0.3599

Aug28

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 206.82 M, Net Income 35.04 M, EPS 0.3711

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More